87628-25-9

Basic information

• Product Name: 1H-Pyrazolo[4,3-c]pyridine, 5-acetyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-
• CAS NO: 87628-25-9
• Molecular Formula: C14H14FN3O
• Molecular Weight: 259.283
• Mol File: 87628-25-9.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazolo[4,3-c]pyridine, 5-acetyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazolo[4,3-c]pyridine, 5-acetyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-(87628-25-9)
• EPA Substance Registry System: 1H-Pyrazolo[4,3-c]pyridine, 5-acetyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-(87628-25-9)

Safety Data

• Hazardous Substances Data: 87628-25-9(Hazardous Substances Data)

Usage

Structure

1H-Pyrazolo[4,3-c]pyridine, 5-acetyl-3-(4-fluorophenyl)-4,5,6,7-tetrahydro-

Type

Tetrahydro derivative of pyrazolopyridine

Contains

Acetyl group, fluorophenyl group

Usage

Commonly used in pharmaceutical research and development

Potential therapeutic applications

Antipsychotic, anticonvulsant, neurological disorders, mood disorders (requires further research)

Upstream product

• 55459-60-4 1-(4-(morpholin-4-yl)-3,6-dihydro-2H-pyridin-1-yl)ethanone 
• 32161-06-1 1-acetyl-4-piperidinone 
• 87642-26-0 1-Acetyl-3-(4-fluoro-benzoyl)-piperidin-4-one 

Downstream Products

• 1427414-61-6 1-[((R)-3-(4-fluoro-phenyl)-1-indan-1-yl)-1,4,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-5-yl]ethanone 
• 87628-04-4 3-(4-Fluoro-phenyl)-5-methyl-1-(3-phenyl-propyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87628-12-4 3-(4-Fluoro-phenyl)-5-methyl-1-(1-phenyl-ethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87629-61-6 5-Benzyl-1-ethyl-3-(4-fluoro-phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87642-62-4 3-(4-Fluoro-phenyl)-1-(1-phenyl-ethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87642-54-4 3-(4-Fluoro-phenyl)-1-(3-phenyl-propyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87642-52-2 3-(4-Fluoro-phenyl)-1-phenethyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87628-21-5 3-(4-Fluoro-phenyl)-1-hexyl-5-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87629-84-3 3-(4-Fluoro-phenyl)-5-methyl-1-pentyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87628-08-8 1-Butyl-3-(4-fluoro-phenyl)-5-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87642-72-6 3-(4-Fluoro-phenyl)-1-hexyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87628-06-6 3-(4-Fluoro-phenyl)-5-methyl-1-propyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87642-70-4 3-(4-Fluoro-phenyl)-1-pentyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 
• 87629-39-8 1-Ethyl-3-(4-fluoro-phenyl)-5-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine 

Relevant articles and documents

Substituted 4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridines, Their Use as Medicament, and Pharmaceutical Preparations Comprising Them

The invention relates to substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines of formula (I), their use as medicament, and pharmaceutical preparations comprising them. The compounds of formula (I) act on the TASK-1 potassium channel. The compounds are particularly suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.

INDANYL-SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

The invention relates to substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines of formula (I), their use as medicament, and pharmaceutical preparations comprising them. The compounds of formula I act on the TASK-1 potassium channel. The compounds are suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.

SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[4,3-C]PYRIDINES, THEIR USE AS MEDICAMENT, AND PHARMACEUTICAL PREPARATIONS COMPRISING THEM

The invention relates to substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines of formula (I), their use as medicament, and pharmaceutical preparations comprising them. The compounds of formula (I) act on the TASK-1 potassium channel. The compounds are suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter.